CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.430
-0.250 (-9.33%)
At close: Oct 23, 2025, 4:00 PM EDT
2.310
-0.120 (-4.94%)
After-hours: Oct 23, 2025, 7:18 PM EDT

CytoMed Therapeutics Statistics

Total Valuation

GDTC has a market cap or net worth of $28.04 million. The enterprise value is $25.84 million.

Market Cap28.04M
Enterprise Value 25.84M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

GDTC has 11.54 million shares outstanding.

Current Share Class 11.54M
Shares Outstanding 11.54M
Shares Change (YoY) n/a
Shares Change (QoQ) -0.00%
Owned by Insiders (%) 17.95%
Owned by Institutions (%) 0.43%
Float 3.59M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 53.96
Forward PS 104.43
PB Ratio 5.51
P/TBV Ratio 4.99
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 45.08
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.81, with a Debt / Equity ratio of 0.07.

Current Ratio 5.81
Quick Ratio 4.31
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -169.20

Financial Efficiency

Return on equity (ROE) is -42.33% and return on invested capital (ROIC) is -24.06%.

Return on Equity (ROE) -42.33%
Return on Assets (ROA) -22.85%
Return on Invested Capital (ROIC) -24.06%
Return on Capital Employed (ROCE) -46.02%
Revenue Per Employee $13,330
Profits Per Employee -$67,065
Employee Count43
Asset Turnover 0.08
Inventory Turnover 0.07

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -0.20% in the last 52 weeks. The beta is -0.36, so GDTC's price volatility has been lower than the market average.

Beta (5Y) -0.36
52-Week Price Change -0.20%
50-Day Moving Average 2.04
200-Day Moving Average 2.27
Relative Strength Index (RSI) 62.30
Average Volume (20 Days) 199,186

Short Selling Information

The latest short interest is 28,459, so 0.25% of the outstanding shares have been sold short.

Short Interest 28,459
Short Previous Month 42,851
Short % of Shares Out 0.25%
Short % of Float 0.79%
Short Ratio (days to cover) 2.01

Income Statement

In the last 12 months, GDTC had revenue of $573,193 and -$2.88 million in losses. Loss per share was -$0.25.

Revenue573,193
Gross Profit 530,297
Operating Income -2.77M
Pretax Income -2.89M
Net Income -2.88M
EBITDA -2.50M
EBIT -2.77M
Loss Per Share -$0.25
Full Income Statement

Balance Sheet

The company has $2.24 million in cash and $384,501 in debt, giving a net cash position of $1.86 million or $0.16 per share.

Cash & Cash Equivalents 2.24M
Total Debt 384,501
Net Cash 1.86M
Net Cash Per Share $0.16
Equity (Book Value) 5.67M
Book Value Per Share 0.49
Working Capital 2.65M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.48 million and capital expenditures -$658,035, giving a free cash flow of -$3.07 million.

Operating Cash Flow -2.48M
Capital Expenditures -658,035
Free Cash Flow -3.07M
FCF Per Share -$0.27
Full Cash Flow Statement

Margins

Gross Margin 92.52%
Operating Margin -482.59%
Pretax Margin -504.08%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GDTC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -10.41%
FCF Yield -11.10%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GDTC has an Altman Z-Score of 14.7 and a Piotroski F-Score of 3.

Altman Z-Score 14.7
Piotroski F-Score 3